TD Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $971K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $379K | Sell |
|
|||||
|
2024
Q1 | $1.96M | Sell |
|
|||||
|
2023
Q4 | $6.47M | Sell |
|
|||||
|
2023
Q3 | $4.7M | Buy |
|
|||||
|
2023
Q2 | $4.18M | Buy |
|
|||||
|
2023
Q1 | $2.2M | Buy |
|
|||||
|
2022
Q4 | $1.64M | Sell |
|
|||||
|
2022
Q3 | $2.04M | Buy |
|
|||||
|
2022
Q2 | $1.57M | Buy |
|
|||||
|
2022
Q1 | $2.32M | Sell |
|
|||||
|
2021
Q4 | $3.19M | Buy |
|
|||||
|
2021
Q3 | $2.08M | Sell |
|
|||||
|
2021
Q2 | $2.98M | Sell |
|
|||||
|
2021
Q1 | $3.6M | Sell |
|
|||||
|
2020
Q4 | $9.79M | Sell |
|
|||||
|
2020
Q3 | $10M | Sell |
|
|||||
|
2020
Q2 | $12.4M | Buy |
|
|||||
|
2020
Q1 | $10.4M | Sell |
|
|||||
|
2019
Q4 | $12.1M | Buy |
|
|||||
|
2019
Q3 | $7.48M | Buy |
|
|||||
|
2019
Q2 | $4.42M | Buy |
|
|||||
|
2019
Q1 | $4.29M | Buy |
|
|||||
|
2018
Q4 | $2.38M | Buy |
|
|||||
|
2018
Q3 | $2.23M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.23M | Sell |
|
|||||
|
2017
Q2 | $1.74M | Sell |
|
|||||
|
2017
Q1 | $2.94M | Sell |
|
|||||
|
2016
Q4 | $3.3M | Sell |
|
|||||
|
2016
Q3 | $4.51M | Sell |
|
|||||
|
2016
Q2 | $4.9M | Sell |
|
|||||
|
2016
Q1 | $4.96M | Buy |
|
|||||
|
2015
Q4 | $4.65M | Sell |
|
|||||
|
2015
Q3 | $4.46M | Buy |
|
|||||
|
2015
Q2 | $5.4M | Sell |
|
|||||
|
2015
Q1 | $4.29M | Buy |
|
|||||
|
2014
Q4 | $3.75M | Buy |
|
|||||
|
2014
Q3 | $2.85M | Buy |
|
|||||
|
2014
Q2 | $2.42M | Buy |
|
|||||
|
2014
Q1 | $1M | Buy |
|
|||||
|
2013
Q4 | $947K | Buy |
|
|||||
|
2013
Q3 | $898K | Buy |
|
|||||
|
2013
Q2 | $525K | Buy |
|